Within the Nordic region, healthcare innovation and growth are considered a top priority and clinical trials are regarded as a key area for delivery innovation, evidenced by local governments incentivising such efforts. Due to the cost of innovation and clinical trials in general, collaboration is an important consideration when operating in the area.
Against this backdrop, OCT Nordics will allow companies from within this Nordic-specific hub to come together and discuss proven strategies to improve and create partnerships within clinical trials and medical devices.
Key presentations include:
Considering wider corporate strategy in relation to vendor selection - Anita Dahl – R&D Outsourcing Manager, LEO Pharma
Exploring clinical supply processes and perspectives from a small biotech - Lars Heslet – Chief Scientific Officer, Serendex
Small company insights for successful clinical supply chain vendor evaluation - Eric Leire – CEO, DanDrit Biotech